177 results on '"Li, Jingao"'
Search Results
2. Advancing precise diagnosis of nasopharyngeal carcinoma through endoscopy-based radiomics analysis
3. Exploring the restoration stability of abandoned open-pit mines by vegetation resilience indicator based on the LandTrendr algorithm
4. Involved site radiation therapy in stage I-III nasopharyngeal carcinoma with limited lymph node burden (ISRT-NPC) or elective region irradiation: a study protocol for a multicenter non-inferiority randomized controlled phase III clinical trial
5. Intensity modulated radiation therapy in elderly patients with nasopharyngeal carcinoma
6. Selectively sparing of the supraclavicular area during intensity-modulated radiotherapy in nasopharyngeal carcinoma: A double-center observation study
7. Constructing an individualized surveillance framework for nasopharyngeal carcinoma based on a dynamic risk-adapted approach
8. Efficacy and safety of KL-A167 in previously treated recurrent or metastatic nasopharyngeal carcinoma: a multicenter, single-arm, phase 2 study
9. Infiltrating B-cell subtypes and associated hub genes in nasopharyngeal carcinoma identified from integrated RNA sequencing data and immunohistochemistry
10. Molecular characteristics of pediatric nasopharyngeal carcinoma using whole-exome sequencing
11. Infiltrating B-cell subtypes and associated hub genes in nasopharyngeal carcinoma identified from integrated single-cell and bulk-RNA sequencing data.
12. The prognostic value of deep learning-based percentage of tumour-infiltrating lymphocytes in nasopharyngeal carcinoma.
13. Efficacy and Safety of Nimotuzumab in Combination with Radiotherapy or Chemoradiotherapy for Local Advanced Head and Neck Cancer: A Systematic Review and Meta-analysis
14. Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
15. Camrelizumab versus placebo in combination with gemcitabine and cisplatin as first-line treatment for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st): a multicentre, randomised, double-blind, phase 3 trial
16. The Global Research of Artificial Intelligence on Nasopharyngeal Carcinoma: A Visualization and Bibliometric Analysis
17. Exploring the Restoration Stability of Abandoned Open-Pit Mines by Vegetation Resilience Indicator Based on Landtrendr Algorithm
18. Endoscopy-Based Radiomics Analysis for Precise Diagnosis of Nasopharyngeal Carcinoma: From Static Images to Video Analysis
19. Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma
20. A dosimetric and radiobiological evaluation of VMAT following mastectomy for patients with left-sided breast cancer
21. Nutritional Status and Incidence of Radiation-Induced Oral Mucositis in Nasopharyngeal Carcinoma Patients Treated with Chemoradiotherapy.
22. Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial
23. An Automated Skill Assessment Framework Based on Visual Motion Signals and a Deep Neural Network in Robot-Assisted Minimally Invasive Surgery
24. Dual-responsive probe and DNA interstrand crosslink precursor target the unique redox status of cancer cells.
25. Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
26. Anoikis resistant mediated by FASN promoted growth and metastasis of osteosarcoma
27. Serum and urine metabolomics analyses reveal metabolic pathways and biomarkers in relation to nasopharyngeal carcinoma
28. RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma
29. Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging
30. Impaired geriatric 8 score is associated with worse survival after radical intensity modulated radiation therapy in elderly patients with nasopharyngeal carcinoma.
31. A Signature of N6-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell Carcinoma
32. Cover Image
33. Comparison of an in‐house hybrid DIR method to NiftyReg on CBCT and CT images for head and neck cancer
34. Efficacy and Safety of KL-A167 in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Multicenter, Single-Arm, Phase 2 Study
35. A Fabric Defect Detection Method Based on Deep Learning
36. A clinical trial to compare a 3D‐printed bolus with a conventional bolus with the aim of reducing cardiopulmonary exposure in postmastectomy patients with volumetric modulated arc therapy
37. Efficacy, safety, and biomarker analysis of Camrelizumab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma (CAPTAIN study)
38. Expressing MLH1 in HCT116 cells increases cellular resistance to radiation by activating the PRKAC
39. Effects of locoregional radiotherapy in de novo metastatic nasopharyngeal carcinoma: A real-world study
40. Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study
41. SEC61G overexpression and DNA amplification correlates with prognosis and immune cell infiltration in head and neck squamous cell carcinoma
42. Chapitre V • Utilisation des équipements d’imagerie pour contrôler la position du patient
43. Relationship between C-reactive protein and clinical stage in nasopharyngeal carcinoma
44. Retrospective Analysis of a Modified Irrigation Method for Nasopharyngeal Carcinoma Patients With Post-Radiation Nasopharyngeal Necrosis
45. A Phase II Randomized Clinical Trial and Mechanistic Studies Using Improved Probiotics to Prevent Oral Mucositis Induced by Concurrent Radiotherapy and Chemotherapy in Nasopharyngeal Carcinoma
46. A Dosimetric and Radiobiological Evaluation of VMAT Following Mastectomy for Patients With Left-sided Breast Cancer
47. High Expression of Hyaluronan-Mediated Motility Receptor Predicts Adverse Outcomes: A Potential Therapeutic Target for Head and Neck Squamous Cell Carcinoma
48. Retracted: Inhibition of Nasopharyngeal Carcinoma by Beta-Lapachone Occurs by Targeting the Mammalian Target of Rapamycin (mTOR)/PI3K/AKT Pathway, Reactive Oxygen Species (ROS) Production, and Autophagy Induction
49. Upregulation of fatty acid synthase in MYC and BCL‑2 double‑expressor lymphoma
50. JUPITOR-02: Randomized, Double-Blind, Phase 3 Study of Toripalimab or Placebo Plus Cisplatin and Gemcitabine as First-Line Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.